4//SEC Filing
Cislini Jeff 4
Accession 0001610717-25-000250
CIK 0001628171other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:07 PM ET
Size
5.1 KB
Accession
0001610717-25-000250
Insider Transaction Report
Form 4
Cislini Jeff
General Counsel
Transactions
- Sale
Common Stock
2025-06-20$39.61/sh−1,912$75,736→ 54,093 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025.
- [F2]This transaction was executed in multiple trades in prices ranging from $39.26 to $40.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 49,054 restricted stock units.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001969082
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 4:07 PM ET
- Size
- 5.1 KB